Here's Why Corcept Therapeutics (NASDAQ:CORT) Has Caught The Eye Of Investors

Simply Wall St01/02 02:39

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires2024/12/31 21:58

Corcept Therapeutics Files New Drug Application for Relacorilant

MT Newswires2024/12/31 06:42

Corcept Therapeutics Submits New Drug Application To FDA For Its Proprietary, Selective Cortisol Modulator, Relacorilant, To Treat Patients With Cushing's Syndrome

Benzinga2024/12/31 06:16

Will Corcept Therapeutics Incorporated (CORT) Make You Rich In 2025?

Yahoo Finance2024/12/25 12:13

Corcept Therapeutics Presents Phase 3 Long-Term Extension Study Of Relacorilant Demonstrated Durable Cardiometabolic Improvements In Patients With Hypercortisolism

Benzinga2024/12/16 21:04